CoChat

Novel Therapy for Male Hypogonadism

Carrasquillo, Robert, Chu, Kevin, Ramasamy, Ranjith · 2018 · Current Urology Reports

The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.

Abstract

Purpose of review Hypogonadism and the treatment of low testosterone is increasingly a subject of medical inquiry and controversy. The few treatments that are FDA-approved such as testosterone topicals, injections, and pellets create significant demand from patients for treatments with more convenient means of administration, fewer adverse effects, and the ability to maintain male fertility. Off-label drugs are in abundant use for low testosterone, including selective estrogen receptor modulators, gonadotropins, and aromatase inhibitors.Recent findings In this review, we summarize the evidence in support of commonly used treatments for male hypogonadism, as well as discuss recent updates in the development of novel therapeutics. New therapies include nasal testosterone, new oral testosterone formulations, anabolic-androgenic steroids, and selective androgen receptor modulators.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11934-018-0816-x

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 71 references

Research works printed but not linked: 2

  1. Ceponis J, Yadav P, Swerdloff RS, Wang C. Chapter 11: Testosterone therapy: transdermal androgens. Testosterone: from basic to clinical aspects. Springer, 2017.
  2. Testopel (testosterone pellets). prescribing information. Rye: Slate pharmaceuticals, Inc.; 2013.

Cited by

See all 31

Metadata

Authors
Carrasquillo, R., Chu, K., & Ramasamy, R.
Affiliations
University of Miami (US)
Corresponding author
Carrasquillo, Robert
Venue
Current Urology Reports
Published
2018-06-09
Volume
19
Issue
8
Pages
63-63
ISSN
  • 1527-2737 (ISSN-L)
  • 1534-6285
OpenAlex
W2805473064
Cited by
31
References
70
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 11 · 2019: 4
FWCI
0.77
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Current Urology Reports (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
male hypogonadism, androgen deficiency, testosterone replacement therapy, anabolic steroids, selective androgen receptor modulators, selective estrogen receptor modulators, gonadotropins, aromatase inhibitors, male fertility preservation, off-label drug use
MeSH terms
Administration, Intranasal, Administration, Oral, Gonadotropins, Humans, Hypogonadism, Male, Testosterone, Hormone Replacement Therapy, Selective Estrogen Receptor Modulators, Testosterone Congeners, Aromatase Inhibitors, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel Therapy for Male Hypogonadism. https://app.cochat.ai/papers/10.1007/s11934-018-0816-x
The paper
Carrasquillo, R., Chu, K., & Ramasamy, R. (2018). Novel Therapy for Male Hypogonadism. Current Urology Reports. https://doi.org/10.1007/s11934-018-0816-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.